Gene · 406932
Papers3,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Moderate evidence exists for four microRNAs as potential biomarkers for tendinopathies and degenerative tendon ruptures at the upper extremity in elderly patients: conclusion of a systematic review with best-evidence synthesis. | J Exp Orthop | 2023 | 37563331 | PubTator, text mining | PubMed |
| Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. | Genes Dis | 2023 | 37554181 | PubTator, text mining | PubMed |
| The role of microRNAs in pathophysiology and diagnostics of metabolic complications in obstructive sleep apnea patients. | Front Mol Neurosci | 2023 | 37547923 | PubTator, text mining | PubMed |
| Recent advances of exosomal circRNAs in cancer and their potential clinical applications. | J Transl Med | 2023 | 37525158 | PubTator, text mining | PubMed |
| MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. | Biochem Biophys Rep | 2023 | 37521375 | PubTator, text mining | PubMed |
| MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity. | Pharmaceutics | 2023 | 37514018 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. | Int J Mol Sci | 2023 | 37511413 | PubTator, text mining | PubMed |
| Epigenetic Modifications of MiRNAs in Osteoarthritis: A Systematic Review on Their Methylation Levels and Effects on Chondrocytes, Extracellular Matrix and Joint Inflammation. | Cells | 2023 | 37508486 | PubTator, text mining | PubMed |
| MiR-320a upregulation improves IL-1β-induced osteoarthritis via targeting the DAZAP1 and MAPK pathways. | J Orthop Surg Res | 2023 | 37507717 | PubTator, text mining | PubMed |
| JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1. | Genes Dis | 2023 | 37492742 | PubTator, text mining | PubMed |
| Influence of technical and maternal-infant factors on the measurement and expression of extracellular miRNA in human milk. | Front Immunol | 2023 | 37492577 | PubTator, text mining | PubMed |
| Dexmedetomidine attenuates neuroinflammation and microglia activation in LPS-stimulated BV2 microglia cells through targeting circ-Shank3/miR-140-3p/TLR4 axis. | Eur J Histochem | 2023 | 37491974 | PubTator, text mining | PubMed |
| Aggregation-Induced Emission (AIE), Life and Health. | ACS Nano | 2023 | 37486125 | PubTator, text mining | PubMed |
| Tissue engineering in growth plate cartilage regeneration: Mechanisms to therapeutic strategies. | J Tissue Eng | 2023 | 37483459 | PubTator, text mining | PubMed |
| Crosstalk between oxidative stress and epigenetic marks: New roles and therapeutic implications in cardiac fibrosis. | Redox Biol | 2023 | 37482041 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming. | Stem Cell Rev Rep | 2023 | 37474869 | PubTator, text mining | PubMed |
| Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II. | Front Pharmacol | 2023 | 37456736 | PubTator, text mining | PubMed |
| Role of salivary miRNAs in the diagnosis of gastrointestinal disorders: a mini-review of available evidence. | Front Genet | 2023 | 37456668 | PubTator, text mining | PubMed |
| Lung cancer-derived exosomal miR-132-3p contributed to interstitial lung disease development. | World J Surg Oncol | 2023 | 37454094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406932/papers?page=11